It sounds like the UK is leading the way in high-tech healthcare – but doctors are saying the idea is ethically questionable
Author Archives: biocon
The 20-day-old monkey embryos could reopen the debate about how long the human variety should be allowed to grow in a dish.
Once, a diagnosis of extensively drug-resistant TB meant quick death. A three-drug regimen cures most patients in just months.
Advocates for genomic research in Africa are worried about fallout from a dispute that has roiled the Wellcome Sanger Institute, a major genome research center in Hinxton, U.K.
A new law warns biohackers not to edit their genes at home.
From the ubiquitous lager beer to the local seasonal cider, hybrids play pivotal roles in fermentation.
An international team of researchers headed by scientists at the University of California (UC), Berkeley, has used CRISPR-Cas9 genome editing to turn fruit flies that might otherwise represent a handy snack for frogs and birds, into potentially poisonous prey that could cause anything that eats them—including humans—to vomit.
Researchers at MIT have resolved that bacterial resistance should be overcome by hook or by hook.
A gene therapy being developed to treat Duchenne muscular dystrophy (DMD) successfully and safely stopped the severe muscle deterioration associated with the rare, genetic disease in both small and large animal models.
Is your CRISPR workflow labor intensive and prolonged? Inefficient for your gene editing requirements? The new CRISPR-SNIPER technology and services delivered by REPROCELL could be the solution.